Figure 3
From: A Bayesian re-assessment of two Phase II trials of gemcitabine in metastatic nasopharyngeal cancer
Stage 2 posterior distributions, corresponding to different priors, for the chemotherapy-naïve group.
Figure 3 | British Journal of Cancer
